1. ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC
   Caterina De Rosa et al, 2024, Scientific Reports CrossRef
2. Identification of novel candidate biomarkers for pancreatic adenocarcinoma based on TCGA cohort
   Yang Jie et al, 2021, Aging CrossRef
3. A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients
   Silvia Marconi et al, 2022, Cancers CrossRef
4. Production and characterization of single-chain variable fragment antibodies targeting the breast cancer tumor marker nectin-4
   Ching-Hsuan Liu et al, 2024, Frontiers in Immunology CrossRef